SynthesisHealth technology assessment (Winchester, England)2020

Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.

Nigel Fleeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.